138 related articles for article (PubMed ID: 38123377)
1. Acute megakaryoblastic leukemia in a pediatric patient.
Strasser B; Haushofer A
Hematol Transfus Cell Ther; 2024; 46(3):321-322. PubMed ID: 38123377
[No Abstract] [Full Text] [Related]
2. Trisomy 3 as an acquired cytogenetic abnormality in primary acute megakaryoblastic leukemia.
Azad VF; Mehrvar A; Mehrvar N
J Cancer Res Ther; 2018 Sep; 14(Supplement):S800-S802. PubMed ID: 30249908
[TBL] [Abstract][Full Text] [Related]
3. Clinical and hematological profile of acute megakaryoblastic leukemia: a 2 year study.
Jayasudha AV; Nair RA; Jacob PM; Renu S; Anila KR; Sindhu Nair P; Priya Kumari T; Kusuma Kumary P
Indian J Hematol Blood Transfus; 2015 Jun; 31(2):169-73. PubMed ID: 25825554
[TBL] [Abstract][Full Text] [Related]
4. MLL-MLLT10 fusion gene in pediatric acute megakaryoblastic leukemia.
Morerio C; Rapella A; Tassano E; Rosanda C; Panarello C
Leuk Res; 2005 Oct; 29(10):1223-6. PubMed ID: 16111539
[TBL] [Abstract][Full Text] [Related]
5. Megakaryoblastic leukemia and Down's syndrome: a review.
Zipursky A; Peeters M; Poon A
Pediatr Hematol Oncol; 1987; 4(3):211-30. PubMed ID: 2978961
[TBL] [Abstract][Full Text] [Related]
6. Pan myeloid antigen-negative pediatric acute megakaryoblastic leukemia.
Cetin N; Lorsbach RB
Pediatr Blood Cancer; 2014 Nov; 61(11):2089-91. PubMed ID: 24962432
[TBL] [Abstract][Full Text] [Related]
7. Megakaryoblastic disorders in children.
Lorsbach RB
Am J Clin Pathol; 2004 Dec; 122 Suppl():S33-46. PubMed ID: 15690641
[TBL] [Abstract][Full Text] [Related]
8. The c-sis gene expression in cells from a patient with acute megakaryoblastic leukemia and Down's syndrome.
Sunami S; Fuse A; Simizu B; Eguchi M; Hayashi Y; Sugita K; Nakazawa S; Okimoto Y; Sato T; Nakajima H
Blood; 1987 Aug; 70(2):368-71. PubMed ID: 2955817
[TBL] [Abstract][Full Text] [Related]
9. Lineage switch in a pediatric patient with KMT2A-MLLT3 from acute megakaryoblastic leukemia to T cell acute lymphoblastic leukemia at the fourth relapse after allo-HSCT: with literature review.
Gao L; Lu J; Li J; Hu Y; Lu Y; Du W; Hu S
Int J Hematol; 2023 May; 117(5):781-785. PubMed ID: 36472792
[TBL] [Abstract][Full Text] [Related]
10. Cryptic KMT2A/MLLT10 fusion detected by next-generation sequencing in a case of pediatric acute megakaryoblastic leukemia.
Kim Y; Kim B; Seong MW; Lee DS; Hong KT; Kang HJ; Yun J; Chang YH
Cancer Genet; 2023 Aug; 276-277():36-39. PubMed ID: 37478796
[TBL] [Abstract][Full Text] [Related]
11. Acute panmyelosis with myelofibrosis: an entity distinct from acute megakaryoblastic leukemia.
Orazi A; O'Malley DP; Jiang J; Vance GH; Thomas J; Czader M; Fang W; An C; Banks PM
Mod Pathol; 2005 May; 18(5):603-14. PubMed ID: 15578075
[TBL] [Abstract][Full Text] [Related]
12. Mixed-phenotype acute leukemia, T/megakaryoblastic: does it really exist?
Mansoor N; Javed O; Rafiq N; Aali A; Meraj F
J Hematop; 2023 Mar; 16(1):49-55. PubMed ID: 38175376
[TBL] [Abstract][Full Text] [Related]
13. Gene mutation landscape of a rare patient with acute megakaryoblastic leukemia after treatment of intracranial germ cell tumor.
Wang LX; Liao WJ; Jiang YH; Chen C; Lu WS; Yin F; Ning HY
Front Oncol; 2023; 13():1093434. PubMed ID: 37228497
[TBL] [Abstract][Full Text] [Related]
14. Molecular features, prognosis, and novel treatment options for pediatric acute megakaryoblastic leukemia.
De Marchi F; Araki M; Komatsu N
Expert Rev Hematol; 2019 May; 12(5):285-293. PubMed ID: 30991862
[TBL] [Abstract][Full Text] [Related]
15. The changing scenario of non-Down syndrome acute megakaryoblastic leukemia in children.
Masetti R; Guidi V; Ronchini L; Bertuccio NS; Locatelli F; Pession A
Crit Rev Oncol Hematol; 2019 Jun; 138():132-138. PubMed ID: 31092368
[TBL] [Abstract][Full Text] [Related]
16. Acute mono-megakaryoblastic leukemia associated with extreme thrombocytosis and complex karyotype abnormalities.
Hu R; Li J; Hu Y; Zhang J; Miao M; Zhu K; Liao A; Yang W; Liu Z
Am J Case Rep; 2013; 14():157-160. PubMed ID: 23826456
[TBL] [Abstract][Full Text] [Related]
17. The biology of pediatric acute megakaryoblastic leukemia.
Gruber TA; Downing JR
Blood; 2015 Aug; 126(8):943-9. PubMed ID: 26186939
[TBL] [Abstract][Full Text] [Related]
18. CBFA2T3-GLIS2-dependent pediatric acute megakaryoblastic leukemia is driven by GLIS2 and sensitive to navitoclax.
Neault M; Lebert-Ghali CÉ; Fournier M; Capdevielle C; Garfinkle EAR; Obermayer A; Cotton A; Boulay K; Sawchyn C; St-Amand S; Nguyen KH; Assaf B; Mercier FE; Delisle JS; Drobetsky EA; Hulea L; Shaw TI; Zuber J; Gruber TA; Melichar HJ; Mallette FA
Cell Rep; 2023 Sep; 42(9):113084. PubMed ID: 37716355
[TBL] [Abstract][Full Text] [Related]
19. Advances in molecular characterization of pediatric acute megakaryoblastic leukemia not associated with Down syndrome; impact on therapy development.
Li J; Kalev-Zylinska ML
Front Cell Dev Biol; 2023; 11():1170622. PubMed ID: 37325571
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic significance of chimeric fusion gene analysis in pediatric acute megakaryoblastic leukemia].
Tamefusa K; Fukutake K; Ishida H; Tamura A; Endo M; Hamamoto K; Koga Y; Yamada M; Kanamitsu K; Fujiwara K; Washio K; Shimada A
Rinsho Ketsueki; 2019; 60(2):99-105. PubMed ID: 30842387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
